Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)

National University Hospital, Singapore · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
breastcancer
advanced refractory solid tumors, advanced triple negative breast cancers, metastatic triple negative breast cancers, selinexor, talazoparib, breast cancer, triple negative, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 909685
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.